Beckenham, United Kingdom

Terence W Smith

This inventor holds 4 USPTO granted patents. Top assignee: Burroughs Wellcome Co.. Active years: 1985-1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Orpington, GB (1985)
  • Beckenham, GB (1989 - 1990)

Company Filing History:


Years Active: 1985-1990

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Terence W. Smith: Innovator in Asthma Treatment

Introduction

Terence W. Smith is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of medicine, particularly in the treatment of asthma. With a total of 4 patents to his name, Smith's work has had a meaningful impact on healthcare.

Latest Patents

One of Smith's latest patents is a method of treating asthma. This patent describes peptides that exhibit analgesic, antidiarrhoeal, and antitussive activity. These compounds are effective in reversing neuronally-mediated bronchoconstriction in mammals. The application of these peptides is particularly relevant in the palliation of conditions characterized by such a state, especially asthma in human beings.

Career Highlights

Throughout his career, Terence W. Smith has been associated with Burroughs Wellcome Co., where he has focused on developing innovative treatments. His work has been instrumental in advancing therapeutic options for patients suffering from respiratory conditions.

Collaborations

Smith has collaborated with notable colleagues, including Geoffrey Allan and John J. Adcock. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Terence W. Smith's contributions to asthma treatment through his innovative patents highlight his dedication to improving patient care. His work continues to influence the medical field and offers hope for those affected by respiratory conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…